| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/25/2003 | US20030235595 Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
| 12/25/2003 | US20030235591 Comprises hepatitis B surface antigens |
| 12/25/2003 | US20030235589 Comprises chondroprotective agents, an agent which promotes cartilage anabolic activity, and an agent that inhibits cartilage catabolism; for sustained release; for treatment of neurodegenerative disorders |
| 12/25/2003 | US20030235547 An oil phase, an aqueous phase, a surfactant of water-in-oil type, a surfactant of oil-in-water type and a branched or crosslinked polyelectrolyte |
| 12/25/2003 | US20030235541 Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| 12/25/2003 | US20030235537 Pulmonary delivery in treating disorders of the central nervous system |
| 12/25/2003 | US20030235536 Administering an aerosol, a conjugate of a therapeutic agent and an FcRn binding partner, for treating resipiratory system disorders, drug delivery of an antibody, immunizing vaccines |
| 12/25/2003 | US20030235534 Methods and compositions for radioimmunotherapy of brain and CNS tumors |
| 12/24/2003 | WO2003106659A2 Aptamer-toxin molecules and methods for using same |
| 12/24/2003 | WO2003106644A2 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 12/24/2003 | WO2003106619A2 Multifunctional polypeptides |
| 12/24/2003 | WO2003106592A2 Ether alcohols used as solvents and emulsifiers and dispersions containing said ether alcohols |
| 12/24/2003 | WO2003106589A1 A nanoporous particle with a retained target |
| 12/24/2003 | WO2003106536A2 Heat-sensitive polymers and heat reversible gels derived therefrom |
| 12/24/2003 | WO2003106487A1 Immunogenic conjugates |
| 12/24/2003 | WO2003106382A2 Reversed liquid crystalline phases with non-paraffin hydrophobes |
| 12/24/2003 | WO2003105985A1 Method of nanoextraction and nanoextract |
| 12/24/2003 | WO2003105908A2 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 12/24/2003 | WO2003105907A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 12/24/2003 | WO2003105906A1 A process for the preparation of piroxicam: b-cyclodextrin inclusion compounds |
| 12/24/2003 | WO2003105905A1 Controlled release composition comprising felodipine and method of preparation thereof |
| 12/24/2003 | WO2003105904A1 Calixarenes for use as excipient for an active substance |
| 12/24/2003 | WO2003105894A1 Stabilized liquid anti-rsv antibody formulations |
| 12/24/2003 | WO2003105882A1 Composition comprising viscous fibers and viscosity-lowering proteins |
| 12/24/2003 | WO2003105880A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/24/2003 | WO2003105867A1 Quaternised ammonium cyclodextrin compounds |
| 12/24/2003 | WO2003105859A1 Powdery respiratory tonic composition |
| 12/24/2003 | WO2003105858A1 Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain |
| 12/24/2003 | WO2003105852A1 Use of dopamine partial agonists for the treatment of the restless legs syndrome and corresponding pharmaceutical preparation |
| 12/24/2003 | WO2003105847A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105841A1 Antifungal medicinal compositions |
| 12/24/2003 | WO2003105826A2 "soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors." |
| 12/24/2003 | WO2003105817A1 Novel parenteral composition comprising propofol |
| 12/24/2003 | WO2003105816A1 Method of treating rosacea by topical application of a cyclohexane derivative |
| 12/24/2003 | WO2003105808A1 Abuse-protected administration form |
| 12/24/2003 | WO2003105804A1 Ibuprofen suspension |
| 12/24/2003 | WO2003105803A1 Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
| 12/24/2003 | WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | WO2003105781A2 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105775A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 12/24/2003 | WO2003105768A2 Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus |
| 12/24/2003 | WO2003105767A2 Antifungal parenteral products |
| 12/24/2003 | WO2003105765A2 Phospholipid micelles in liposomes as solubilizers for water-insoluble compounds |
| 12/24/2003 | WO2003105761A2 Immunotoxin as a therapeutic agent and uses thereof |
| 12/24/2003 | WO2003105753A2 Methods and compositions for grafting functional loops into a protein |
| 12/24/2003 | WO2003105724A2 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | WO2003105661A2 Materials with both bioadhesive and biodegradable components |
| 12/24/2003 | WO2003105607A1 Nano-sized self-assembled structured liquids |
| 12/24/2003 | WO2003105606A1 Stable emulsions of oils in aqueous solutions and methods for producing same |
| 12/24/2003 | WO2003096975A3 Pharmaceutical compositions and methods of using c-21 modified epothilone derivatives |
| 12/24/2003 | WO2003090662A3 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
| 12/24/2003 | WO2003089593A3 Adjuvant enhanced immunotherapy |
| 12/24/2003 | WO2003089568A3 Method of inhibiting restenosis |
| 12/24/2003 | WO2003088765A3 Functional foods containing a phospholipid-containing stable matrix |
| 12/24/2003 | WO2003084519A3 Aerosol formulation for inhalation comprising a tiotropium salt |
| 12/24/2003 | WO2003082340B1 Injectable veterinary composition for small animals |
| 12/24/2003 | WO2003074025A3 Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 12/24/2003 | WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/24/2003 | WO2003070153A3 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives |
| 12/24/2003 | WO2003068925A3 Production of a protein delivery system for in vivo therapeutic treatment |
| 12/24/2003 | WO2003068166A3 Treatment of ophthalmic disorders using urea and urea derivatives |
| 12/24/2003 | WO2003063831A3 Immediate release dosage forms containing solid drug dispersions |
| 12/24/2003 | WO2003063826A3 Ophthalmic compositions including oil-in-water emulsions, and methods for making and using the same |
| 12/24/2003 | WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 12/24/2003 | WO2003051299A3 Sulfhydryl rifamycins and uses thereof |
| 12/24/2003 | WO2003045429A3 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 12/24/2003 | WO2003037296A3 Methods and dosage forms for improving the bioavailability of therapeutic agents |
| 12/24/2003 | WO2003022239A3 Stable water in oil aminophylline emulsions |
| 12/24/2003 | WO2003017975A3 Method for producing solutions |
| 12/24/2003 | WO2003011230A3 Modified reoviral therapy |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | WO2003000235A9 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 12/24/2003 | WO2003000113A3 Compositions and methods for the diagnosis and treatment of tumor |
| 12/24/2003 | WO2002102825A3 Fluorescently labelled locked nucleic acids |
| 12/24/2003 | WO2002068676A3 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 12/24/2003 | WO2002068562A8 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use |
| 12/24/2003 | WO2002068561A8 Cubic liquid crystalline phase precursor |
| 12/24/2003 | WO2002067994A3 Compounds comprising an analgesic molecule linked to a vector that can vectorise said molecule through the hematoencephalic barrier and pharmaceutical compositions containing same |
| 12/24/2003 | WO2002062947A8 Hematopoietic growth factor inducible neurokinin-1 gene |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore |
| 12/24/2003 | CN1463177A Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 12/24/2003 | CN1462763A Nano granule of polylysine amylum and its preparation method as well as application gene carrier |
| 12/24/2003 | CN1131711C Method of mfg. porous matrix-type controlled release system using emulsion tech |
| 12/24/2003 | CA2491846A1 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 12/24/2003 | CA2489854A1 Antifungal medicinal compositions |
| 12/24/2003 | CA2489724A1 Immunogenic conjugates |
| 12/24/2003 | CA2489708A1 A process for the preparation of piroxicam: .beta.-cyclodextrin inclusion compounds |
| 12/24/2003 | CA2489632A1 Stabilized liquid anti-rsv antibody formulations |
| 12/24/2003 | CA2489534A1 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 12/24/2003 | CA2489467A1 Humanized monoclonal antibody hpam4 |
| 12/24/2003 | CA2489391A1 Stable emulsions of oils in aqueous solutions and methods for producing same |
| 12/24/2003 | CA2489250A1 Composition comprising viscous fibers and viscosity-lowering proteins |
| 12/24/2003 | CA2489106A1 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | CA2488896A1 Multifunctional polypeptides |
| 12/24/2003 | CA2488879A1 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 12/24/2003 | CA2488872A1 Antifungal parenteral products |
| 12/24/2003 | CA2488858A1 Immunotoxin as a therapeutic agent and uses thereof |
| 12/24/2003 | CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension |
| 12/24/2003 | CA2488821A1 Methods and compositions for grafting functional loops into a protein |